Shank3 Protein Sh3 And Multiple Ankyrin Repeat Domains 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SHANK3 (SH3 and Multiple Ankyrin Repeat Domains 3) is a critical scaffolding protein located at the postsynaptic density (PSD) of excitatory synapses. It plays a fundamental role in synapse formation, dendritic spine morphology, and synaptic signaling. Mutations in SHANK3 are causative for Phelan-McDermid syndrome (22q13.3 deletion syndrome) and have been implicated in autism spectrum disorder (ASD), intellectual disability, and neurodegenerative diseases including Alzheimer's disease and Parkinson's disease.
| SHANK3 Protein |
|---|
| Protein Name | SHANK3 |
| Gene | [SHANK3](/genes/shank3) |
| UniProt ID | [Q9BYB4](https://www.uniprot.org/uniprot/Q9BYB4) |
| PDB ID(s) | 5Y5Z, 6CXN |
| Molecular Weight | 223.1 kDa |
| Subcellular Localization | Postsynaptic density, [dendritic spines](/cell-types/dendritic-spines) |
| Protein Family | SHANK family (ProSAP/SHANK) |
| Expression | Brain (cortex, [hippocampus](/brain-regions/hippocampus), striatum) |
¶ Domain Architecture
SHANK3 contains multiple protein-protein interaction domains:
- ANK repeat domains (1-5): Mediate interactions with cytoskeletal proteins
- SH3 domain: Binds proline-rich motifs
- PDZ domain: Organizes synaptic protein complexes
- Proline-rich region (PRR): Interacts with cortactin and other SH3-containing proteins
- C-terminal sterile alpha motif (SAM): Mediates homomeric and heteromeric interactions
Multiple SHANK3 isoforms exist with tissue-specific expression:
- Isoform a: Full-length, brain-specific
- Isoform b: Missing ANK repeats 2-3
- Isoform c: Alternative C-terminus
SHANK3 is a master organizer of the postsynaptic density:
- PSD-95 interaction: Links to NMDA receptor complexes via SAP90/PSD-95
- Metabotropic glutamate receptors: Associates with group I mGluRs
- Actin cytoskeleton: Connects to actin via ankyrin repeats
- Synaptic adhesion: Binds to neurexin and other presynaptic proteins
SHANK3 is essential for dendritic spine formation and maintenance:
- Spine density: Knockout reduces spine number by 40-60%
- Spine morphology: Affects head width and neck length
- Synaptic plasticity: Modulates LTP and LTD
- mGluR signaling: Facilitates downstream signaling cascades
- ERK/MAPK pathway: Involved in synaptic plasticity
- PI3K/Akt pathway: Regulates neuronal survival
SHANK3 haploinsufficiency causes 22q13.3 deletion syndrome:
- Prevalence: ~1 in 200,000 births
- Core features: Developmental delay, absent or severely delayed speech, dysmorphic features
- Neurological: Hypotonia, seizures (25-30%), ASD traits
- Additional: Gastrointestinal issues, renal anomalies
SHANK3 mutations are among the most common genetic causes of ASD:
- Frequency: ~0.5-1% of ASD cases
- Inheritance: De novo dominant (most cases)
- Penetrance: Near complete
- Phenotype: Severe language impairment, intellectual disability, repetitive behaviors
SHANK3 involvement in AD includes:
- Synaptic loss: SHANK3 reduction correlates with cognitive decline
- Aβ interaction: Aβ oligomers reduce SHANK3 expression
- Tau pathology: Hyperphosphorylated tau affects SHANK3 localization
- Postsynaptic dysfunction: Early marker of synaptic vulnerability
- Synaptic alterations: SHANK3 changes in PD prefrontal cortex
- LRRK2 interaction: May intersect with LRRK2 signaling pathways
- DBS effects: SHANK3 expression modified by deep brain stimulation
- AAV vectors: Delivering functional SHANK3 to neurons
- CRISPR/Cas9: Correcting pathogenic variants
- Antisense oligonucleotides: Modulating SHANK3 expression
- mGluR5 modulators: Targeting downstream signaling
- BDNF mimetics: Promoting synaptic plasticity
- AMPAkines: Enhancing glutamatergic transmission
- Speech therapy: Maximizing communication potential
- Occupational therapy: Improving motor skills
- Early intervention: Critical for developmental outcomes
The study of Shank3 Protein Sh3 And Multiple Ankyrin Repeat Domains 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.